Absci founder & CEO Sean McClain on The Bio Report podcast
Oct 14, 2021
Our founder and CEO, Sean McClain recently sat down with The Bio Report podcast to discuss how Absci is taking a more holistic approach to drug development by collapsing the process down and addressing the functionality and manufacturability of therapeutic candidates simultaneously. Sean also talked about how Absci is using AI and synthetic biology to reinvent the discovery process, how this is expanding the therapeutic potential of proteins, and how it translates into time and cost benefits.
Listen to the full interview here:
www.absci.com/thebioreporter